Special Issue "Marine Myxobacteria: Sea Secrets from the Slime"
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: 15 May 2018
Dr. Jim La Clair
Xenobe Research Institute, P.O. Box 3052, San Diego, CA, USA
Prof. Dr. Rolf Müller
Department of Microbial Natural Products (MINS), Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Inhoffenstraße 7, 38124 Braunschweig, Germany
Website | E-Mail
Interests: Molecular Biology; Biotechnology; Genetics; Biochemistry; Cancer Research; Analytical Chemistry; Bioengineering; Catalysis
Myxobacteria are one of the most robust producers of secondary metabolites. This special issue reports on the state-of-the-art in the discovery, evaluation and translation of myxobacterial metabolites. The issue will focus on topics related to: whole genome metabolite mining in myxobacteria; natural product biosynthesis in myxobacteria; elucidation of myxobacterial natural product scaffolds; elaboration and establishment of discrete modes of action; understanding of myxobacterial metabolite communication in nature; and, the role in which they play in ongoing and future clinical and commercial applications.Dr. Jim La Clair
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- natural products
- secondary metabolites
- drug discovery
- modes of action
- agricultural agents
- clinical trials
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.
Article 1: Introduction to Issue
Corresponding Author(s): Rolf Muller and Jim La Clair
Topic: Brief overview of the field of marine myxobacteria and the articles in the issue.
Article 2: Metabolic and biosynthetic diversity in marine mycobacteria
Corresponding Author: Rolf Muller
Topic: This article will provide a series of compounds of interest and highlight their biosynthesis.
Article 3: Access to new modes of action from myxobacteria
Corresponding Author: Jim La Clair
Topic: This article will provide an overview of some of the leading new modes of natural product action identified from myxobacteria.
Article 4: Symbiosis in myxobacteria
Corresponding Author: Cole Stevens
Topic: This article will provide an overview of the complex symbioses in myxobacteria. It will highlight the field and how molecular communication between myxobacteria and their interactive hosts is an important emerging field.
Article 5: Future Directions: Potential of novel marine myxobacteria for new secondary metabolites
Corresponding Author: Rolf Muller
Topic: This article will highlight some of the key next steps in the field of marine myxobacteria
Article 6: Clinical and commercial utility
Corresponding Author: Mark Butler
Topic: This article will provide a synopsis of the molecular probes and clinical entries from myxobacteria